Stephan, C.; Ralla, B.; Bonn, F.; Diesner, M.; Lein, M.; Jung, K.
Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy. Cancers 2022, 14, 1560.
https://doi.org/10.3390/cancers14061560
AMA Style
Stephan C, Ralla B, Bonn F, Diesner M, Lein M, Jung K.
Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy. Cancers. 2022; 14(6):1560.
https://doi.org/10.3390/cancers14061560
Chicago/Turabian Style
Stephan, Carsten, Bernhard Ralla, Florian Bonn, Max Diesner, Michael Lein, and Klaus Jung.
2022. "Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy" Cancers 14, no. 6: 1560.
https://doi.org/10.3390/cancers14061560
APA Style
Stephan, C., Ralla, B., Bonn, F., Diesner, M., Lein, M., & Jung, K.
(2022). Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy. Cancers, 14(6), 1560.
https://doi.org/10.3390/cancers14061560